|
NF-kappaB inhibitor
|
CHEBI_73240 |
|
|
molecular quality
|
BAO_0120001 |
|
|
organismal quality
|
BAO_0120002 |
|
|
bronchiectasis
|
DOID_9563 |
|
|
bronchial disease
|
DOID_1176 |
|
|
primary ciliary dyskinesia
|
DOID_9562 |
|
|
ciliopathy
|
DOID_0060340 |
|
|
nasopharyngeal disease
|
DOID_9561 |
|
|
upper respiratory tract disease
|
DOID_974 |
|
|
dextrocardia
|
DOID_9565 |
|
|
congenital heart disease
|
DOID_1682 |
|
|
blood substitute
|
CHEBI_38849 |
|
|
pharmaceutical
|
CHEBI_52217 |
|
|
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor
|
CHEBI_170010 |
|
|
DNA polymerase inhibitor
|
CHEBI_38234 |
|
|
choanal atresia
|
DOID_9574 |
|
|
nasal cavity disease
|
DOID_2163 |
|
|
neonatal candidiasis
|
DOID_9577 |
|
|
candidiasis
|
DOID_1508 |
|
|
human blood serum metabolite
|
CHEBI_85234 |
|
